Extended-release formulation of oxymorphone effective for pain relief in osteoarthritis


The opioid oxymorphone (Numorphan, Endo) delivered in a new extended-release (ER) formulation significantly improves standard measures of pain and physical function in osteoarthritis (OA) patients, researchers reported at the American College of Rheumatology 67th Annual Scientific Meeting.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.